Visión generalGráficoNoticiasTraderScreen

InspireMD Inc/  US45779A8466  /

IEX
11/11/2024  21:57:20 Diferencia +0.13 Volumen Bid- Ask- Máximo del día Price Change Band
2.49USD +5.51% 546
Volumen de negocios: 1,337.51		 -Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 2.49 2.36
GlobeNewswire 06/08 InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05/08 InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment
GlobeNewswire 30/07 InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on T...
GlobeNewswire 01/07 InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
GlobeNewswire 28/05 InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. In...
GlobeNewswire 14/05 InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 07/05 InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tu...
GlobeNewswire 03/04 InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire 26/03 InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational...
GlobeNewswire 06/03 InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
GlobeNewswire 28/02 InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Busine...
GlobeNewswire 12/02 InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neu...
GlobeNewswire 31/01 InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory...
GlobeNewswire 03/01 InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice Presi...
GlobeNewswire 20/12/2023 InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System
GlobeNewswire 27/11/2023 InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of ...
GlobeNewswire 06/11/2023 InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 02/11/2023 InspireMD to Participate in Upcoming November Investor Conferences
GlobeNewswire 01/11/2023 InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Devic...
GlobeNewswire 30/10/2023 InspireMD to Report Third Quarter 2023 Financial Results and Provide Corporate Business Update on Mo...
GlobeNewswire 12/10/2023 InspireMD Supports CMS’ Final National Coverage Determination (NCD) Expanding Coverage of Carotid St...
GlobeNewswire 03/10/2023 InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives
GlobeNewswire 31/08/2023 InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exem...
GlobeNewswire 16/03/2022 InspireMD to Host Key Opinion Leader Event on Carotid Artery Disease Management and Stroke Preventio...
GlobeNewswire 08/03/2022 InspireMD Reports Fourth Quarter and Year-End 2021 Financial Results